This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: The Innovations of Lawrence Argenbright
Introduction
Lawrence Argenbright is an accomplished inventor based in Edison, NJ (US). He holds a patent that contributes significantly to the field of medicine. His work focuses on developing new therapeutic agents that can aid in the treatment of various health conditions.
Latest Patents
Lawrence Argenbright is credited with a patent for "5-Amino or substituted amino 1,2,3-triazoles." This innovative class of compounds is recognized for its potential as antiproliferative agents. These agents are particularly useful in treating and managing psoriasis, inflammatory bowel syndrome, cutaneous leishmaniasis, and certain types of cancer.
Career Highlights
Argenbright is associated with Merck & Co., Inc., a leading global healthcare company. His role at Merck has allowed him to contribute to significant advancements in pharmaceutical research and development. His dedication to innovation in medicine has made a positive impact on patient care.
Collaborations
Some of his notable coworkers include Barbara A. Azzolina and Donald Hupe. Their collaborative efforts have further enhanced the research and development initiatives at Merck.
Conclusion
Lawrence Argenbright's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving healthcare. His work continues to inspire advancements in the treatment of serious health conditions.